Adiponectin, resistin, and GLP-1 are influential in metabolic disorders, thus these findings introduce the concept that biliary signaling may modulate insulin resistance and other metabolic diseases associated with NAFLD. The gene discussed is RETN; the disease is metabolic dysfunction-associated steatotic liver disease.